Award momentum AI Medical Service Inc. recently received the METI Minister's Award in July 2025, signaling strong validation from government and industry. This credibility can be leveraged to open doors with large healthcare systems and hospitals seeking innovative diagnostic AI solutions.

Leadership expansion With new leadership appointments in June 2025 including a new President and Chairman, there is an opportunity to engage the executive team early to align on strategic partnerships, pilot programs, and scaled deployments across markets.

Global partnerships Active collaboration history with Mahidol University in Thailand and a joint research agreement with The Chinese University of Hong Kong indicates openness to international co-development and trials, suggesting potential to propose regional pilots or multi-country deployments.

Early detection focus The company's initial product launch targets early detection of stomach cancer via endoscopic AI, aligning with hospitals and endoscopy centers investing in AI-assisted diagnostics to improve screening yield and workflow efficiency.

Strong funding With a substantial funding round supported by SoftBank Vision Fund 2 and other investors and a reported revenue range of 1-10M USD against $115M in funding, there is room to discuss enterprise-grade deployment, service commitments, and long-term ROI cases with potential large-scale customers.